Speakers:
Kevin Carmen, MD, Kevin Cooper, BS, Tracy Griffith, MD, Herbert Schumm, MD, and Vincent Vanek, MD, FACS, FASPEN have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Kevin Cooper, BS has indicated the presentation may include discussion of any off-label uses of a product.
Explanation Given: We distribute Fentanyl and Xylazine test strips for clients to test their drugs for the presence of these substances. This was an off-label use of a urine dip test strip and considered drug paraphernalia under Ohio law until January 2023.
Planners and other Administrative Support:
Victoria Cannon, BA, Cheryl Kuck, MS, CMA (AAMA), Melanie Woods, MSW, Dawn Mansfield, BSN, RN, Brian Latham, PharmD, Jennifer Lamanna, PhD, Herbert Schumm, MD, Jacob Stabler, Julie Teater, MD, and Mohammad Moinzadeh, LPCC have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.